Jeffrey S Farrow Tarsus Pharmaceuticals, Inc. (TARS) insider trading activity

TARS Quotes by TradingView

Jeffrey S Farrow is Officer of Tarsus Pharmaceuticals, Inc.. Currently has a direct ownership of 18,136 shares of TARS, which is worth approximately $857,832. The most recent transaction as insider was on Jun 18, 2024, when has been sold 10,445 shares (Common Stock) at a price of $27.47 per share, resulting in proceeds of $286,924. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 18.1K
0% 3M change
n/a 12M change
Total Value Held $857,832

Jeffrey S Farrow Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 18 2024
SELL
Open market or private sale
$286,924 $27.47 p/Share
10,445 Reduced 36.55%
18,136 Common Stock
Jun 17 2024
BUY
Exercise of conversion of derivative security
-
27,881 Added 49.38%
28,581 Common Stock

Also insider at

GBT
Global Blood Therapeutics, Inc. Healthcare
Chief Financial Officer
JSF

Jeffrey S Farrow

Officer
South San Francisco, CA

Track Institutional and Insider Activities on TARS

Follow Tarsus Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TARS shares.

Notify only if

Insider Trading

Get notified when an Tarsus Pharmaceuticals, Inc. insider buys or sells TARS shares.

Notify only if

News

Receive news related to Tarsus Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on TARS